Unibest
← Back to patent-cliff list

CAS 290835-85-7

1-(2,6-dichloro-3-fluorophenyl)ethan-1-one

Codes: CRIT-001

Application context (from source-drug indications)

Primary cutaneous anaplastic large cell lymphomaCrizotinibAnaplastic large cell lymphomaCrizotinibNon-small cell lung cancerCrizotinibSchwannomaCrizotinibNeurofibromatosis type IICrizotinibMultiple myelomaCrizotinib

Source drugs (routes using this intermediate)

DrugTierExpiry
CrizotinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Workstert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H- pyrazol-1-yl]piperidine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site[5-Bromo-3-[(1R)-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin -2- yl]amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site2-amino-5-bromopyridin-3-ol
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.